Our Team

Company Management Bhawanjit Brar Ph.D. Co-Founder and Chief Executive Officer Dr. Brar founded Jaan Biotherapeutics in 2015, following 7 years at Zensun USA, where she held various positions including the Vice President of Clinical Research, managing a United States...

Science and Technology

The Problem Ischemic heart disease (IHD) is the single largest cause of death worldwide. In the United States of America alone, there are over 1,000,000 heart attacks every year1.  Limitation of blood flow to the heart causes ischemia and irreversible death of the...

Our Team

Company Management   Bhawanjit Brar Ph.D. Co-Founder and Chief Executive Officer Dr. Brar founded Jaan Biotherapeutics in 2015, following 7 years at Zensun USA, where she held various positions including the Vice President of Clinical Research, managing a United...

The Problem

Ischemic heart disease (IHD) is the single largest cause of death worldwide. In the United States of America alone, there are over 1,000,000 heart attacks every year1.  Limitation of blood flow to the heart causes ischemia and irreversible death of the myocardial...

Objectives

Our Solution Establishment of a therapy that promotes endogenous cardiac myocyte regeneration in the ischemic heart to reduce infarct size offers a potential treatment of IHD, reducing morbidity and mortality.  Inhibition of a specific combination of four mircroRNAs...